Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
Compositions for inducing and maintaining a state of flow in a subject include optically pure S-beta-hydroxybutyrate or non-racemic mixtures enriched with the S-enantiomer. The S-beta-hydroxybutyrate enantiomer modulates the effect of ketone bodies in the subject and controls the rate at which ketosis is achieved. Beta-hydroxybutyric acid is more rapidly absorbed and utilized by the body than salts or esters, enhances taste, and reduces the need to include citric acid or other edible acids. Beta-hydroxybutyrate salts are more slowly absorbed and utilized by the body and can provide one or more electrolytes. Compositions for controlling ketone body level in a subject may contain a dietetically or pharmaceutically acceptable carrier and optically pure S-beta-hydroxybutyrate or non-racemic mixture enriched with S-beta-hydroxybutyrate, wherein the compositions contain from about 50.5% to 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and from about 49.5% to 0% by enantiomeric equivalents of R-beta-hydroxybutyrate.
1 . A composition for raising blood ketone levels in a subject for inducing and maintaining a state of flow in the subject, comprising:
optically pure S-beta-hydroxybutyrate or a non-racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate containing more than 50% and less than 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and less than 50% and more than 0% by enantiomeric equivalents of R-beta-hydroxybutyrate,
wherein the composition provides about 0.5 g to about 25 g of S-beta-hydroxybutyrate in order to cause at least one of: enhanced brain metabolism, improved mental alertness, improved cognitive function, or improved mood.
2 . The composition of claim 1 , wherein the composition provides about 0.75 gram to about 20 grams, or about 1 gram to about 15 grams, or about 1.5 grams to about 12 grams of S-beta-hydroxybutyrate.
3 . The composition of claim 1 , wherein the composition comprises optically pure S-beta-hydroxybutyric acid or a non-racemic mixture comprising more than 50% and less than 100% by enantiomeric equivalents of S-beta-hydroxybutyric acid and less than 50% and more than 0% by enantiomeric equivalents of R-beta-hydroxybutyric acid, wherein the composition is free of beta-hydroxybutyrate salts.
4 . The composition of claim 1 , wherein the composition comprises a mixture of optically pure S-beta-hydroxybutyric acid and at least one optically pure S-beta-hydroxybutyrate salt or ester.
5 . The composition of claim 1 , wherein the composition comprises a non-racemic mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate, wherein the non-racemic mixture includes:
at least one S-beta-hydroxybutyrate salt or ester;
at least one R-beta-hydroxybutyrate salt or ester;
S-beta-hydroxybutyric acid; and
R-beta-hydroxybutyric acid.
6 . The composition of claim 1 , wherein the composition comprises a non-racemic mixture that contains 50.5% to 99.5% by enantiomeric equivalents of S-beta-hydroxybutyrate and 49.5% to 0.5% by enantiomeric equivalents of R-beta-hydroxybutyrate, or 51% to 99% by enantiomeric equivalents of S-beta-hydroxybutyrate and 49% to 1% by enantiomeric equivalents of R-beta-hydroxybutyrate, or 52% to 98% by enantiomeric equivalents of S-beta-hydroxybutyrate and 48% to 2% by enantiomeric equivalents of R-beta-hydroxybutyrate.
7 . The composition of claim 1 , wherein the composition comprises 75% to 99.9% by molar equivalents of total beta-hydroxybutyrate salt and 25% to 0.1% by molar equivalents of total beta-hydroxybutyric acid, or 80% to 99.8% by molar equivalents of total beta-hydroxybutyrate salt and 20% to 0.2% by molar equivalents of total beta-hydroxybutyric acid.
8 . The composition of claim 1 , further comprising S-1,3-butanediol or non-racemic mixture enriched with S-1,3-butanediol.
9 . The composition of claim 1 , further comprising at least one short chain fatty acid having less than 6 carbons, or a mono-, di- or triglyceride of the at least one short chain fatty acid.
10 . The composition of claim 1 , further comprising at least one supplement selected from vitamin, mineral, caffeine, theobromine, nootropic, and herbal supplement.
11 . The composition of claim 1 , wherein the composition provides an amount of S-beta-hydroxybutyrate that induces the state of flow in the subject for at least about 30 minutes, or at least about 60 minutes, at least about 90 minutes, at least about 120 minutes, at least about 180 minutes, at least about 240 minutes, or at least about 300 minutes.
12 . A kit for administering ketone bodies to a subject, comprising:
the composition of claim 1 ;
a container in which the composition is placed; and
a measuring device configured to hold therein a unit dose, or fraction thereof, of the composition, wherein a unit dose of the composition contains about 0.5 g to about 25 g of S-beta-hydroxybutyrate.
13 . The kit of claim 12 , wherein the container is selected from the group consisting of carton, box, can, jar, bag, pouch, bottle, jug, liquid squeeze bottle with integrated measuring device, and keg, and wherein the measuring device is selected from the group consisting of cup, scoop, syringe, dropper, spatula, spoon, and colonic irrigation device.
14 . A composition for raising blood ketone levels in a subject for inducing and maintaining a state of flow in the subject, comprising:
optically pure S-beta-hydroxybutyrate or a non-racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate containing more than 50% and less than 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and less than 50% and more than 0% by enantiomeric equivalents of R-beta-hydroxybutyrate,
wherein the composition is provided in a dosage form selected from a tablet, capsule, powder, food product, food additive, flavored beverage, vitamin fortified beverage, non-alcoholic beverage, flavored beverage additive, vitamin fortified beverage additive, non-alcoholic beverage additive, candy, sucker, pastille, food supplement, flavored mouth spray, or suppository,
wherein the dosage form provides about 0.5 g to about 25 g of S-beta-hydroxybutyrate in order to cause at least one of: enhanced brain metabolism, improved mental alertness, improved cognitive function, or improved mood.
15 . The composition of claim 14 , wherein the composition contains about 0.75 gram to about 20 grams, or about 1 gram to about 15 grams, or about 1.5 grams to about 12 grams of S-beta-hydroxybutyrate.
16 . The composition of claim 14 , wherein the composition comprises optically pure S-beta-hydroxybutyric acid or a non-racemic mixture comprising more than 50% and less than 100% by enantiomeric equivalents of S-beta-hydroxybutyric acid and less than 50% and more than 0% by enantiomeric equivalents of R-beta-hydroxybutyric acid, wherein the composition is free of beta-hydroxybutyrate salts.
17 . The composition of claim 14 , further comprising S-1,3-butanediol or non-racemic mixture enriched with S-1,3-butanediol.
18 . The composition of claim 14 , further comprising at least one short chain fatty acid having less than 6 carbons, or a mono-, di- or triglyceride of the at least one short chain fatty acid.
19 . The composition of claim 14 , further comprising at least one supplement selected from vitamin, mineral, caffeine, theobromine, nootropic, and herbal supplement.
20 . A composition for raising blood ketone levels in a subject for inducing and maintaining a state of flow in the subject, comprising:
a dietetically or pharmaceutically acceptable carrier selected from the group consisting of tablet, capsule, powder, food product, food additive, flavored beverage, vitamin fortified beverage, non-alcoholic beverage, flavored beverage additive, vitamin fortified beverage additive, non-alcoholic beverage additive, candy, sucker, pastille, food supplement, flavored mouth spray, and suppository; and
optically pure S-beta-hydroxybutyrate or a non-racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate containing more than 50% and less than 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and less than 50% and more than 0% by enantiomeric equivalents of R-beta-hydroxybutyrate,
wherein the composition provides about 0.5 g to about 25 g of S-beta-hydroxybutyrate in order to cause at least one of: enhanced brain metabolism, improved mental alertness, improved cognitive function, or improved mood.